Results 181 to 190 of about 121,491 (304)
Abstract Background Migrant women account for a substantial proportion of new HIV diagnoses in Europe, yet remain underrepresented in HIV prevention research. Little is known about how legal status and national policy context shape engagement with PrEP among migrant women, particularly those without secure documentation.
Haoyi Wang +17 more
wiley +1 more source
Abstract Objectives Bone health is negatively affected in people with HIV, and the risks of osteoporosis and fragility fractures are increased. The objective of this study was to describe the characteristics of those accessing bone health screening and identify factors associated with osteoporosis.
Rhys Nicholas +3 more
wiley +1 more source
What factors drive unmet need for modern contraception among sexually active adolescent girls and young women in Zambia: a multilevel analysis. [PDF]
Phiri M, Namayawa S, Odimegwu C.
europepmc +1 more source
Delphi‐based expert consensus for diagnosis and management of common hyperpigmentation disorders in Indian dermatology practice, integrating evidence review, iterative voting, and consensus‐driven recommendations. ABSTRACT Hyperpigmentation disorders are prevalent in individuals with skin of color and are associated with considerable psychosocial ...
Rashmi Sarkar +12 more
wiley +1 more source
ABSTRACT Introduction Fully automated thrombin generation (TG) assays facilitate the transition from research to clinical application. We conducted a multicenter inter‐laboratory study using the ST Genesia analyzer to evaluate assay performance and establish reference intervals in healthy adults from Spain and Portugal.
Diego Velasco‐Rodríguez +21 more
wiley +1 more source
From Birth to Unintended Pregnancy: Postnatal Contraception Failures in the First Postpartum Year. [PDF]
Javed M, Baloch FN, Verma V.
europepmc +1 more source
Abstract Autosomal polycystic kidney disease (ADPKD) is the most common form of inherited kidney disease. The international guideline developer, Kidney Disease: Improving Global Outcomes (KDIGO), published a 2025 clinical practice guideline reflecting advances in genetic testing and the first disease‐modifying agent, tolvaptan.
Mia E. Abdy +26 more
wiley +1 more source
Epilepsy, Intellectual and Developmental Disabilities, and Contraception in U.S. Medicaid Claims Data. [PDF]
Kirkpatrick L +12 more
europepmc +1 more source

